Value through Innovation17 January 2013

Diabetes News and Information

This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Diabetes Press Releases

back 1 2 3 4 5 6 7 8 next

22.09.2010	New phase III data further support the safety and efficacy profile of Boehringer Ingelheim’s investigational drug linagliptin - For non-US healthcare media
26.06.2010	Boehringer Ingelheim announces results of phase III data showing that linagliptin significantly lowered blood glucose with an excellent safety and tolerability profile - For non-US healthcare media only
28.09.2009	Boehringer Ingelheim`s diabetes pipeline continues to advance as the Company announces conclusion of robust Phase III pivotal trials programme for linagliptin - For medical media, outside the US only
06.06.2009	New data from Boehringer Ingelheim`s ongoing linagliptin trial programme show promising safety and efficacy results - For medical media, outside the US only
13.05.2009	Boehringer Ingelheim and DeveloGen AG announce agreement in the field of diabetes, obesity and the metabolic syndrome

back 1 2 3 4 5 6 7 8 next

Further Press Releases in our Archive

Diabetes Related News Room

Resources
Videos

Diabetes Related Documents

Diabetes Video Gallery

Mode of Action of DPP-4 Inhibitors
- Watch the Video
Diabetes Complications Animation
- Watch the video
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)